Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma

Urologic Oncology: Seminars and Original Investigations

Volumn 31, Issue 8, 2013, Pages 1643-1649

  Kim, Kwang Hyun ^a   You, Dalsan ^a   Jeong, In Gab ^a   Hong, Jun Hyuk ^a   Ahn, Hanjong ^a   Kim, Choung Soo ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Carcinoma; Kidney pelvis; Transitional cell; Ureter; Urinary bladder

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BLADDER TUMOR; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER SPECIFIC SURVIVAL; CANCER SURGERY; CARCINOMA IN SITU; CLINICAL FEATURE; CYSTECTOMY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; KIDNEY PELVIS; MAJOR CLINICAL STUDY; MALE; MUSCLE INVASIVE BLADDER CANCER; NEPHROURETERECTOMY; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; URETER; URETER TUMOR; URINARY TRACT CARCINOMA;

CARCINOMA; KIDNEY PELVIS; TRANSITIONAL CELL; URETER; URINARY BLADDER;

AGED; CARCINOMA, TRANSITIONAL CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUSCLES; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEPHRECTOMY; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; URETER; URINARY BLADDER NEOPLASMS; URINARY TRACT; UROLOGIC NEOPLASMS;

EID: 84886290778     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2012.04.014     Document Type: Article

References (29)

1. Azémar M.D., Comperat E., Richard F., et al. Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: Frequency, risk factors, and surveillance. Urol Oncol 2009, 29:130-136.
2. Kang C.H., Yu T.J., Hsieh H.H., et al. The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract. Cancer 2003, 98:1620-1626.
3. Mullerad M., Russo P., Golijanin D., et al. Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma. J Urol 2004, 172:2177-2181.
4. Raman J.D., Ng C.K., Boorjian S.A., et al. Bladder cancer after managing upper urinary tract transitional cell carcinoma: Predictive factors and pathology. BJU Int 2005, 96:1031-1035.
5. van der Poel H.G., Antonini N., van Tinteren H., et al. Upper urinary tract cancer: Location is correlated with prognosis. Eur Urol 2005, 48:438-444.
6. Matsui Y., Utsunomiya N., Ichioka K., et al. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract. Urology 2005, 65:279-283.
7. Zigeuner R.E., Hutterer G., Chromecki T., et al. Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location. BJU Int 2006, 98:1181-1186.
8. Sakamoto N., Naito S., Kotoh S., et al. Recurrence of bladder tumors following surgery for transitional cell carcinoma of the upper urinary tract. Eur Urol 1991, 20:136-139.
9. Krogh J., Kvist E., Rye B. Transitional cell carcinoma of the upper urinary tract: Prognostic variables and post-operative recurrences. Br J Urol 1991, 67:32-36.
10. Abe T., Shinohara N., Harabayashi T., et al. Pathological characteristics and clinical course of bladder tumour developing after nephroureterectomy. BJU Int 2010, 105:1102-1106.
11. Raman J.D., Sosa R.E., Vaughan E.D., et al. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma. Urology 2007, 69:251-254.
12. Sylvester R.J., van der Meijden A.P., Oosterlinck W., et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006, 49:466-475.
13. Fernandez-Gomez J., Madero R., Solsona E., et al. Predicting non-muscle-invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: The CUETO scoring model. J Urol 2009, 182:2195-2203.
14. Catto J.W., Azzouzi A.R., Amira N., et al. Distinct patterns of microsatellite instability are seen in tumours of the urinary tract. Oncogene 2003, 22:8699-8706.
15. Catto J.W., Yates D.R., Rehman I., et al. Behavior of urothelial carcinoma with respect to anatomical location. J Urol 2007, 177:1715-1720.
16. Harris A.L., Neal D.E. Bladder cancer-field vs. clonal origin. N Engl J Med 1992, 326:759-761.
17. Kakizoe T. Development and progression of urothelial carcinoma. Cancer Sci 2006, 97:821-828.
18. Sidransky D., Frost P., Von Eschenbach A., et al. Clonal origin bladder cancer. N Engl J Med 1992, 326:737-740.
19. Habuchi T., Takahashi R., Yamada H., et al. Metachronous multifocal development of urothelial cancers by intraluminal seeding. Lancet 1993, 342:1087-1088.
20. Hafner C., Knuechel R., Stoehr R., et al. Clonality of multifocal urothelial carcinomas: 10 Years of molecular genetic studies. Int J Cancer 2002, 101:1-6.
21. Miyake H., Hara I., Kamidono S., et al. Multifocal transitional cell carcinoma of the bladder and upper urinary tract: Molecular screening of clonal origin by characterizing CD44 alternative splicing patterns. J Urol 2004, 172:1127-1129.
22. O'Brien T., Ray E., Singh R., et al. Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: A prospective, multicenter, randomized clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C trial). Eur Urol 2011, 60:703-710.
23. Kume H., Teramoto S., Tomita K., et al. Bladder recurrence of upper urinary tract cancer after laparoscopic surgery. J Surg Oncol 2006, 93:318-322.
24. Koga F., Nagamatsu H., Ishimaru H., et al. Risk factors for the development of bladder transitional cell carcinoma following surgery for transitional cell carcinoma of the upper urinary tract. Urol Int 2001, 67:135-141.
25. Ouzzane A., Colin P., Xylinas E., et al. Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy. Eur Urol 2011, 60:1258-1265.
26. Park J., Ha S.H., Min G.E., et al. The protective role of renal parenchyma as a barrier to local tumor spread of upper tract transitional cell carcinoma and its impact on patient survival. J Urol 2009, 182:894-899.
27. Park S., Hong B., Kim C.S., et al. The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract. J Urol 2004, 171:621-625.
28. Favaretto R.L., Shariat S.F., Chade D.C., et al. The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center. Eur Urol 2010, 58:574-580.
29. Sarkis A.S., Dalbagni G., Cordon-Cardo C., et al. Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: A marker for disease progression. J Natl Cancer Inst 1993, 85:53-59.